CHA Biomedical Group completed a KRW100bn investment in Kakao Healthcare.

CHA Biomedical Group, a global healthcare group, completed a KRW100bn investment in Kakao Healthcare, a healthcare company. Kakao Healthcare plans to further strengthen its business competitiveness centered on AI-based mobile health management solution PASTA, medical data businesses including HRS and Heycon, and hospital concierge service Care Chat with the total business funding of 100 billion won.